US Patent 7829082 Catheter composition and uses thereof
Patent 7829082 was granted and assigned to Genentech on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+300 characters)
Article
Patent abstract
A composition useful for removal of fibrin-bound blood clots from a catheter comprises water, a fibrinolytically effective amount of a plasminogen activator, and a preservatively effective amount of a bacteriostatic organic alcohol. The composition does not comprise a chelating agent.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07829082 Catheter composition and uses thereof US Patent 7829082 Catheter composition and uses thereof
Infobox
Patent Number
0782908200
Patent Number
782908200
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078290820
Date of Patent
November 9, 2010
0Patent Application Number
114262630
Date Filed
June 23, 2006
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078290820
Date of Patent
November 9, 2010
0Patent Application Number
114262630
Date Filed
June 23, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07829082 Catheter composition and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07829082
Date of patent
November 9, 2010
Patent application number
11426263
Date Filed
June 23, 2006
Patent primary examiner
Find more entities like US Patent 7829082 Catheter composition and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
